Cyclin/CDK associated proteins, and uses related thereto
    51.
    发明授权
    Cyclin/CDK associated proteins, and uses related thereto 失效
    细胞周期蛋白/ CDK相关蛋白及其相关用途

    公开(公告)号:US5981702A

    公开(公告)日:1999-11-09

    申请号:US531439

    申请日:1995-09-21

    CPC classification number: C07K14/4738 A01K2217/05 A61K48/00 C07K2319/00

    Abstract: The present invention relates to the discovery in mammalian cells, particularly human cells, of novel S-phase kinase associated proteins, p19 and p45, referred to herein as "Skp". As described herein, these proteins are components of the tumor cell-specific cyclin A/CDK2 complex and function to facilitate DNA replication. Interference with p45 function in vivo prevented entry into S-phase in both normal and transformed cells. Binding data indicated that p45 and p19 associate with each other in a binary complex. Moreover, p45 is required for p19 binding to cyclin A/CDK2.

    Abstract translation: 本发明涉及在哺乳动物细胞,特别是人类细胞中发现的新型S期激酶相关蛋白p19和p45,在本文中称为“Skp”。 如本文所述,这些蛋白质是肿瘤细胞特异性细胞周期蛋白A / CDK2复合物的组分,并且有助于DNA复制。 与体内p45功能的干扰阻止了在正常细胞和转化细胞中进入S期。 绑定数据表明p45和p19在二元复合体中彼此相关联。 此外,p19是p19与细胞周期蛋白A / CDK2结合所必需的。

    Substrate trapping protein tyrosine phosphatases
    52.
    发明授权
    Substrate trapping protein tyrosine phosphatases 失效
    底物捕获蛋白酪氨酸磷酸酶

    公开(公告)号:US5951979A

    公开(公告)日:1999-09-14

    申请号:US144925

    申请日:1998-09-01

    CPC classification number: C12N9/16 A61K38/00 C12N2799/026

    Abstract: Novel protein tyrosine phosphatases in which the invariant aspartate residue is replaced with an alanine residue and which bind to a tyrosine phosphorylated substrate and are catalytically attenuated are described. Also described are methods of identifying tyrosine phosphorylated proteins which complex with the described protein tyrosine phosphatases.

    Abstract translation: 描述了新的蛋白酪氨酸磷酸酶,其中不变的天冬氨酸残基被丙氨酸残基替代并结合酪氨酸磷酸化底物并被催化衰减。 还描述了鉴定与所述蛋白质酪氨酸磷酸酶复合的酪氨酸磷酸化蛋白质的方法。

    Bioassay for transforming genes and genes detected thereby
    56.
    发明授权
    Bioassay for transforming genes and genes detected thereby 失效
    用于转化从而检测到的基因和基因的生物测定

    公开(公告)号:US4866166A

    公开(公告)日:1989-09-12

    申请号:US647881

    申请日:1984-08-31

    Applicant: Michael Wigler

    Inventor: Michael Wigler

    CPC classification number: C07K16/32 C12Q1/02

    Abstract: A sensitive bioassay for transforming genes based on the tumorigenicity of cotransfected NIH3T3 cells in nude mice is disclosed. Genes mcf2 and mcf3 have been detected in tissue breast cancer using this assay.

    Abstract translation: 公开了一种基于裸转染的NIH3T3细胞的致瘤性转化基因的敏感生物测定法。 使用该测定法在组织乳腺癌中检测到mcf2和mcf3基因。

    COMPOSITIONS AND SYSTEMS FOR RNA-PROGRAMABLE CELL EDITING AND METHODS OF MAKING AND USING SAME

    公开(公告)号:US20250011765A1

    公开(公告)日:2025-01-09

    申请号:US18649873

    申请日:2024-04-29

    Abstract: A readrRNA (RNA sensing by Endogenous ADAR) molecule is a modular RNA molecule that facilitates sensing and detection of a cell type or cell status of a cell, including a cell of a mammalian nervous system, such as a neuronal or non-neuronal cell of the mammalian central and/or peripheral nervous system, and/or facilitates delivery of an effector protein to the selected cell. A composition that includes such a modular RNA molecule and another nucleic acid (linked or unlinked to the modular RNA molecule) is a CellREADR (Cell access through RNA sensing by Endogenous ADAR). CellREADR senses the presence of a selected cell RNA in a cell of a mammalian nervous system via readrRNA and leverages RNA editing mediated by ADAR (adenosine deaminase acting on RNA) for coupling the detection of a cell-defining RNA with translation of one or more effector proteins in a cell of a mammalian nervous system.

Patent Agency Ranking